Page last updated: 2024-10-27

gabapentin and Hemangioma, Cavernous, Central Nervous System

gabapentin has been researched along with Hemangioma, Cavernous, Central Nervous System in 1 studies

Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.

Hemangioma, Cavernous, Central Nervous System: A vascular anomaly composed of a collection of large, thin walled tortuous VEINS that can occur in any part of the central nervous system but lack intervening nervous tissue. Familial occurrence is common and has been associated with a number of genes mapped to 7q, 7p and 3q. Clinical features include SEIZURES; HEADACHE; STROKE; and progressive neurological deficit.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Engin, EF1
Polat, B1
Ertan Akan, G1
Akgül, E1

Other Studies

1 other study available for gabapentin and Hemangioma, Cavernous, Central Nervous System

ArticleYear
Cerebral proliferative angiopathy accompanied by cerebral cavernous malformation: A case report.
    Clinical neurology and neurosurgery, 2021, Volume: 210

    Topics: Adult; Anticonvulsants; Antipsychotic Agents; Cerebral Small Vessel Diseases; Gabapentin; Haloperido

2021